Jobs Report, Palantir, Pinterest, AMD, PayPal, Disney, and More to Watch This Week
ON Semiconductor, Pfizer, Uber, McDonald's, and many more will report earnings this week. Economic r…

SBA loan origination volumes and gain-on-sale margins (secondary market premiums fluctuate with investor demand)
Net interest margin expansion or compression driven by funding costs versus loan yields in niche verticals
Credit quality metrics in specialized portfolios (veterinary, dental, funeral home charge-offs typically run 0.3-0.8% vs 1.0%+ for general commercial)
Loan portfolio growth rate in target verticals and new vertical expansion announcements
moderate-high - Live Oak's borrowers (veterinary practices, dental offices, funeral homes) exhibit recession-resistant demand characteristics, but loan origination volumes are highly sensitive to small business formation rates and acquisition activity within target verticals. During economic expansions, veterinary practice acquisitions by private equity and consolidation activity drive loan demand. In recessions, origination volumes decline 20-40% as business owners delay expansion, though existing portfolio performance remains relatively stable given non-discretionary nature of services. The 12% revenue growth suggests current expansion-phase dynamics.
High sensitivity with asymmetric impact. Rising rates benefit net interest margin as loan yields reprice faster than deposit costs (estimated 60% of loans are floating or reprice within 12 months vs 40% of deposits). However, higher rates reduce SBA loan secondary market premiums (gain-on-sale margins compress 200-400bps when 10-year Treasury rises 100bps) and dampen small business borrowing demand. The current 48.3% gross margin (likely reflecting strong gain-on-sale activity) is vulnerable to rate volatility. Conversely, falling rates compress NIM but expand SBA loan sale premiums and origination volumes.
SBA program changes or government shutdown disrupting loan originations and secondary market liquidity (SBA 7(a) program subject to annual authorization and policy changes)
Consolidation in target verticals (veterinary, dental) by large corporate buyers reducing addressable market for independent practice financing
Technology disruption enabling non-bank lenders or fintech competitors to replicate vertical-specific underwriting models at lower cost
growth - The 30.2% EPS growth, 34% net income growth, and 20.7% one-year return attract growth investors seeking exposure to a differentiated banking model with above-average profitability (10% net margin vs 15-25% for typical regional banks suggests room for margin expansion). The 26.1% FCF yield appeals to value-oriented investors, while the 1.5x price-to-book suggests the market is pricing in continued ROE expansion from current 9.1% toward peer group averages of 12-15%. The specialty lending focus and technology platform create a growth narrative distinct from traditional regional banks.
Trend
+7.6% vs SMA 50 · +32.0% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $427.4M $422.3M–$432.6M | — | $2.47 | — | ±2% | Low1 |
FY2024 | $497.7M $497.2M–$498.2M | ▲ +16.4% | $1.71 | ▼ -31.0% | ±3% | Low2 |
FY2025 | $572.5M $571.2M–$573.9M | ▲ +15.0% | $1.98 | ▲ +15.9% | ±10% | Moderate3 |
Dividend per payment — last 8 periods
ON Semiconductor, Pfizer, Uber, McDonald's, and many more will report earnings this week. Economic r…

Live Oak Bancshares, Inc. (Nasdaq: LOB) is a financial holding company and parent company of Live Oak Bank. Live Oak Bancshares and its subsidiaries partner with businesses that share a groundbreaking focus on service and technology to redefine banking.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
LOB◀ | $37.17 | -1.14% | $1.7B | 13.7 | +1204.8% | 996.7% | 1500 |
| $312.47 | -0.24% | $842.7B | 14.8 | +330.7% | 2039.3% | 1502 | |
| $328.03 | -0.55% | $628.8B | 28.2 | +1134.0% | 5014.5% | 1498 | |
| $495.46 | -1.48% | $438.6B | 28.4 | +1641.6% | 4564.7% | 1488 | |
| $53.24 | -0.41% | $382.1B | 12.2 | -45.1% | 1592.6% | 1501 | |
| $190.18 | -0.22% | $302.0B | 16.4 | +1147.7% | 1466.4% | 1516 | |
| $923.71 | -0.01% | $274.1B | 15.5 | -138.4% | 1373.0% | 1515 | |
| Sector avg | — | -0.58% | — | 18.5 | +753.6% | 2435.3% | 1503 |